Clinical Trial Update: Effect of Neflamapimod on Brain Inflammation in Alzheimer's Disease Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating nef lamapimod on brain inflammation in patients with Alzheimer disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Neflamapimod (neflamapimod)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED